ALVOFLEX

adalimumab · Alvotech Swiss AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALVOFLEX, covering 2024-10-02 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX [Phase 3]